← Back to guidelines
Cardiology13 papers

Pure red cell aplasia

Last edited: 4/15/2026

Overview

Pure red cell aplasia (PRCA) is a rare hematologic disorder characterized by selective failure of red blood cell production by the bone marrow, often associated with immune-mediated mechanisms. 1

Diagnosis

  • Bone marrow biopsy showing absent or markedly decreased erythroid precursors 1
  • Elevated reticulocyte count with low hemoglobin levels 1
  • Exclusion of other causes of anemia through comprehensive blood work 1
  • Management

  • Blood transfusions for symptomatic relief and to manage anemia 1
  • Corticosteroids as a first-line immunosuppressive treatment 1
  • Consideration of other immunosuppressive agents if corticosteroids are ineffective 1
  • Special Populations

  • Pregnancy: PRCA can occur at any gestational age, often resolves postpartum, but has a high risk of relapse in subsequent pregnancies 1
  • Relapse risk: Women with a history of pregnancy-induced PRCA have a significant chance of recurrence with subsequent pregnancies or with progestin exposure 1
  • Key Recommendations

  • Monitor and manage PRCA during pregnancy with blood transfusions as primary support, with corticosteroids as first-line therapy 1 (Evidence: Moderate)
  • Evaluate for potential relapse in subsequent pregnancies or with progestin use in women with a history of pregnancy-induced PRCA 1 (Evidence: Moderate)
  • Consider alternative immunosuppressive treatments if corticosteroids fail to resolve PRCA 1 (Evidence: Weak)
  • References

    1 Choudry MA, Moffett BK, Laber DA. Pure red-cell aplasia secondary to pregnancy, characterization of a syndrome. Annals of hematology 2007. link

    Original source

    1. [1]
      Pure red-cell aplasia secondary to pregnancy, characterization of a syndrome.Choudry MA, Moffett BK, Laber DA Annals of hematology (2007)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG